MARKET

ICLR

ICLR

ICON PLC
NASDAQ

Real-time Quotes | Nasdaq Last Sale

175.78
+0.66
+0.38%
After Hours: 175.78 0 0.00% 16:07 01/17 EST
OPEN
176.30
PREV CLOSE
175.12
HIGH
176.30
LOW
173.93
VOLUME
225.43K
TURNOVER
--
52 WEEK HIGH
176.30
52 WEEK LOW
127.58
MARKET CAP
9.43B
P/E (TTM)
26.34
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ICLR and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ICLR News

  • Icon PLC (ICLR) Hits Fresh High: Is There Still Room to Run?
  • Zacks.3d ago
  • ICON Sees FY20 EPS $7.55-$7.85 vs $7.71 Est., Sales $2.972B-$3.092B vs $3.03B Est.
  • Benzinga.6d ago
  • ICON plc to Present at 38th Annual J.P. Morgan Healthcare Conference and Issue Financial Guidance for Full Year 2020
  • Business Wire.01/13 13:30
  • Benzinga's Top Upgrades, Downgrades For January 8, 2020
  • Benzinga.01/08 15:56

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About ICLR

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.
More

Webull offers ICON PLC (ICLR) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.